By Patrick Wingrove Oct 29 (Reuters) – Eli Lilly raised its full-year revenue forecast and beat third-quarter earnings expectations on Thursday, propelled by surging demand for injectable weight-loss
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Oct 29 (OPTA) - Scoreboard at close of play on the fourth day of between…
VIDEO SHOWS: ENGLAND STRIKER IVAN TONEY ARRIVING AND DEPARTING SOUTHWARK CROWN COURT / EXTERIORS OF…
Oct 29 (Reuters) - Clorox on Thursday appointed Unilever executive Fabian Garcia as its new…
By Aditya Soni and Deborah Mary Sophia Oct 29 (Reuters) - Cash flow is king…
(Updates share move in paragraph 2, Adds CEO comments in paragraphs 4-6, analysts' estimates in…
(Adds details in paragraph 2, DoorDash CEO comments in paragraph 4) Oct 29 (Reuters) -…